Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts (PAMLTIPS)

Mass General Brigham

Status: Completed

Conditions: Utilization of Software Application Features

Treatments: Other: Reminders

Study type: Interventional

Funder types: Other

Identifiers

NCT00657462

PAMLTIPS

Details and patient eligibility

About

This project will study whether reminder prompts increase PAML Builder application feature utilization.

Full description

This project will study whether reminder prompts increase Pre-Admission Medication List (PAML) Builder application feature utilization. PAML Builder is an application designed and maintained by Partners Information Systems that assists clinicians in medication reconciliation - a process important for patient safety and quality of care. We have determined that several potentially helpful features of the application are not being utilized as frequently as had been expected. These features include:

1. copying the pre-admission medication list (PAML) to the clipboard
2. viewing the detailed audit trail of all changes made to the PAML
3. sorting the list of medications obtained from other electronic sources by therapeutic class.

Reminder prompts (sometimes referred to as "Tip of the Day") have been employed to increase user awareness of underutilized application features. However, anecdotally some users find them unhelpful and potentially irritating. It is therefore important to determine whether reminder prompts accomplish the stated task of increasing application feature utilization. This project will compare PAML Builder application feature utilization before and after a pilot rollout of reminder prompts to determine whether they should be implemented permanently.

Enrollment: 14,122 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• users of the PAML Builder application (physicians, nurses, pharmacists)

Exclusion criteria

• none

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

14,122 participants in 2 patient groups

A

Experimental group

Description:

Receives the intervention (reminders displayed at the startup of the application) for both periods (period 1 and period 2) of the study.

Treatment:

Other: Reminders

B

Active Comparator group

Description:

Receives the intervention (reminders displayed at the application startup) only during the second period (period 2) of the study.

Treatment:

Other: Reminders